FDA Approved: DAPSONE — Supplemental Application (Torrent Pharmaceuticals Limited)

View source ↗

Summary

FDA approved a supplemental application for DAPSONE submitted by Torrent Pharmaceuticals Limited.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dermatitis Herpetiformis
• Leprosy
• Pneumocystis Jirovecii Pneumonia

Drugs mentioned

• DAPSONE (dapsone)

Snippet

SUPPL AP for DAPSONE (DAPSONE)